U.S. Court of Appeals for the District of Columbia Circuit
Teva Pharmaceuticals USA, Inc. v. Robert F. Kennedy, Jr.
This writing
- Type
- Opinion
- Filed
- Aug. 18, 2026
- Case
- Teva Pharmaceuticals USA, Inc. v. Robert F. Kennedy, Jr.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
United States Court of Appeals FOR THE DISTRICT OF COLUMBIA CIRCUIT Argued May 5, 2026 Decided August 18, 2026 No. 25-5425 TEVA PHARMACEUTICALS USA, INC., ET AL., APPELLANTS v. ROBERT F. KENNEDY, JR., IN HIS OFFICIAL CAPACITY AS SECRETARY OF HEALTH AND HUMAN SERVICES AND MEHMET OZ, IN HIS OFFICIAL CAPACITY AS ADMINISTRATOR OF THE CENTERS FOR MEDICARE & MEDICAID SERVICES,…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.